Naseer Humayun, MD
Sleep Medicine · Dalton, GANPI 1932194719
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.9% of the total across 336 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations.
Across 336 payments — averaging $22.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- Jazz Pharmaceuticals Inc.$1K
- Grifols USA, LLC$710
- Insmed, Inc.$623
- Boehringer Ingelheim$548
- Actelion Pharmaceuticals US, Inc.$479
- plus $3K from 28 others
What the payments were for
- Consulting fees$1502%
- Travel & lodging$3144%
- Food & beverage$6,78091%
- Education$2183%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 85 | $1,437 |
| Jazz Pharmaceuticals Inc. | 34 | $1,007 |
| Grifols USA, LLC | 33 | $710 |
| Insmed, Inc. | 25 | $623 |
| Boehringer Ingelheim | 34 | $548 |
| Actelion Pharmaceuticals US, Inc. | 24 | $479 |
| Johnson & Johnson(2 entities) | 3 | $360 |
| United Therapeutics Corporation | 15 | $337 |
| AstraZeneca | 11 | $231 |
| Inspire Medical Systems, Inc. | 5 | $194 |
| Regeneron Healthcare Solutions, Inc. | 3 | $176 |
| Axsome Therapeutics, Inc. | 6 | $161 |
| Baxter Healthcare | 5 | $119 |
| Resmed Corp | 2 | $110 |
| Advanced Respiratory, Inc | 6 | $99 |
| Mylan Specialty L.p. | 6 | $98 |
| ANI Pharmaceuticals, Inc. | 5 | $96 |
| Mallinckrodt Hospital Products Inc. | 4 | $86 |
| Mallinckrodt Enterprises LLC | 3 | $85 |
| Philips North America LLC | 5 | $70 |
| Sanofi | 3 | $63 |
| Shire North American Group Inc | 3 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| Olympus America Inc. | 3 | $41 |
| CSL Behring | 2 | $35 |
| Harmony Biosciences LLC | 1 | $30 |
| Vifor Pharma, Inc. | 1 | $26 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $25 |
| Fisher & Paykel Healthcare Inc | 1 | $25 |
| Pulmonx Corporation | 1 | $23 |
| Genentech USA, Inc. | 1 | $22 |
| Vapotherm Inc | 1 | $21 |
| Circassia Inc. | 1 | $16 |
| Veran Medical Technologies, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Monarch Platform$314
- XYREM$255
- XYWAV$150
- DUPIXENT$135
- AREXVY$121
How this compares
$7,462 in reported general payments places this provider in the 80th percentile of 50 sleep medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 16 | $204,002 |
| ZemairaAlpha-1-Proteinase Inhibitor | 13 | $201,612 |
| LumryzSodium Oxybate | 12 | $148,223 |
| XywavSodium,calcium,mag,pot Oxybate | 12 | $123,440 |
| XembifyImmune Globulin,gamma(Igg)klhw | 13 | $92,623 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 80 | $59,021 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $18,020 |
| SunosiSolriamfetol Hcl | 13 | $12,386 |
| Spiriva RespimatTiotropium Bromide | 12 | $8,144 |
| SymbicortBudesonide/Formoterol Fumarate | 23 | $6,347 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $4,821 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 20 | $2,922 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 91 | $2,764 |
| Modafinil | 34 | $1,348 |
| Ventolin HfaAlbuterol Sulfate | 25 | $1,246 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev, Spiriva Respimat | $548 | $212,14628 claims |
| CSL BehringZemaira | $35 | $201,61213 claims |
| Avadel CNS Pharmaceuticals, LLCLumryz | $25 | $148,22312 claims |
| Grifols USA, LLCXembify | $710 | $92,62313 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $1,437 | $63,84293 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $231 | $24,36736 claims |
| Axsome Therapeutics, Inc.Sunosi | $161 | $12,38613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 50 sleep medicine providers in Georgia.
Other sleep medicine in Dalton
- Erick KimmerlingDalton$3K
- Murad AssaadAtlanta$139K
- Nancy CollopAtlanta$28K
- Scott LeibowitzAtlanta$22K
- Anuj ChandraTrenton$20K
- Chantale BransonAtlanta$17K
- Melissa RhodesCartersville$14K
- James DalySavannah$12K
- Romy HoqueAtlanta$10K
- Praveen RastogiStockbridge$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.